Free Newsletters | Help  

  Current | By Company | NEW Products
Login ID:    Password:    Register for a FREE account
 NEWS

Industry News
Business
Organic
Food & Beverage
Sports Nutrition
Nutraceuticals
Regulatory
Research
Products
Practitioners
Retail
Events
People
On-line


 LISTINGS
  Categories
Products

Profiles
Publishers

 OPINION
  Editorials
Interviews
Up and Comers
Quality Initiatives

 
Blogs
Andrew Stewart  
Marc Ullman FYI Blog
Len Monheit Off The Cuff
James S. Tonkin - Formulating Beverages  
Jim Lassiter -- Good News/Bad News
The Nutrition Business Journal Blog

Join the NPIcenter LinkedIn Group Group
Join the Facebook page Page
Follow us on
Join the Facebook page


 FEATURES
 

Newsletter

  News Feeds
 
 SERVICES
  Log in
Register User
Add Company
Career Center
Advertise

 INFO CENTER
  Help
Contact Us
About NPI
Privacy Policy



 

Advertisement



Share Subscribe to NPIcenter Newsfeed

Danone Research announces further progress in the development of its Alzheimer’s product Souvenaid (TM)
2008-07-22 - Danone Research




Danone Research announces that it has taken an important step forward in the development program for its Alzheimer’s product SouvenaidTM with the successful completion of a first clinical trial.
SouvenaidTM, a multi-nutrient drink, is designed to improve cognitive function, and is the result of ten years of research and development into the potential role of nutrients in neurological diseases. Much of the early development work was conducted at the Massachusetts Institute of Technology, Boston, U.S.A., under the supervision of Professor R.J. Wurtman, Cecil H. Green distinguished Professor of Neuropharmacology.

The clinical trial stage followed on from the experimental and pre-clinical research and toxicological evaluations that were completed in 2006. The trial was designed as a randomised, controlled study with 212 people with Alzheimer’s Disease. The trial was initiated by the Danone Research Centre for Specialised Nutrition, and led by Professor Ph. Scheltens, Director of the Alzheimer Centre at the VU University Medical Centre, Amsterdam, The Netherlands, as the Principal Investigator.

The trial results demonstrate clear proof of concept. The high-level results will be presented at the International Congress on Alzheimer's Disease (ICAD) in Chicago, on July 30th, 2008. Subsequently, the results will be submitted to a peer-reviewed journal.

These first results on SouvenaidTM are very encouraging, and Danone Medical Nutrition will take the next step to continue the development program with a second study, beginning this year, to confirm initial findings.


About Danone Research:
‘Danone Research – Centre for Specialised Nutrition’ (based in Wageningen, The Netherlands) is the Danone R&D innovation centre for the development of new product concepts for baby nutrition and medical nutrition, amongst others for the Nutricia brand. Danone Research is part of Groupe Danone, one of the most successful health food companies in the world. Its mission is to bring health through food to as many people as possible. Apart from baby nutrition and medical nutrition, Danone has two other businesses: fresh dairy products and waters.

 

Advertisement



Sponsored Links: Featured Links:
 

NPIcenter Address and Phone Number
Contact Us | Privacy Policy | Terms of Use | Advertise
New Hope Natural Media

 

SUPPLYEXPO Funtional Foods & Nutraceuticals Magazine Healthy Foods Conferences The Newport Summit - Executive Retreat Nutracon